- Home
- SMC vs TNGX Comparison
SMC vs TNGX Comparison
Compare SMC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMC
- TNGX
- Stock Information
- Founded
- SMC 2009
- TNGX 2014
- Country
- SMC United States
- TNGX United States
- Employees
- SMC N/A
- TNGX N/A
- Industry
- SMC
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- SMC
- TNGX Health Care
- Exchange
- SMC NYSE
- TNGX Nasdaq
- Market Cap
- SMC 398.9M
- TNGX 413.6M
- IPO Year
- SMC 2012
- TNGX N/A
- Fundamental
- Price
- SMC $34.96
- TNGX $3.10
- Analyst Decision
- SMC
- TNGX Strong Buy
- Analyst Count
- SMC 0
- TNGX 8
- Target Price
- SMC N/A
- TNGX $13.14
- AVG Volume (30 Days)
- SMC 82.1K
- TNGX 1.5M
- Earning Date
- SMC 02-05-2025
- TNGX 11-06-2024
- Dividend Yield
- SMC N/A
- TNGX N/A
- EPS Growth
- SMC N/A
- TNGX N/A
- EPS
- SMC N/A
- TNGX N/A
- Revenue
- SMC $450,857,000.00
- TNGX $43,383,000.00
- Revenue This Year
- SMC N/A
- TNGX $27.73
- Revenue Next Year
- SMC N/A
- TNGX N/A
- P/E Ratio
- SMC N/A
- TNGX N/A
- Revenue Growth
- SMC 7.80
- TNGX 15.67
- 52 Week Low
- SMC $15.56
- TNGX $2.70
- 52 Week High
- SMC $40.75
- TNGX $13.01
- Technical
- Relative Strength Index (RSI)
- SMC 39.14
- TNGX 39.37
- Support Level
- SMC $34.23
- TNGX $2.72
- Resistance Level
- SMC $35.64
- TNGX $3.29
- Average True Range (ATR)
- SMC 1.10
- TNGX 0.30
- MACD
- SMC -0.35
- TNGX 0.05
- Stochastic Oscillator
- SMC 17.51
- TNGX 31.25
About SMC SUMMIT MIDSTREAM CORPORATION
Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, primarily shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.